Community-driven development of a modified progression-free survival ratio for precision oncology by Sebastian Schölch, Benedikt Brors, Albrecht Stenzinger, Ursula Ehmer, Ulrich-Frank Pape, Christoph Springfeld, Dirk Jäger, Felix J Hüttner, Andreas Mock, Christoph E Heilig, Simon Kreutzfeldt, Daniel Huebschmann, Christoph Heining, Evelin Schröck, Richard Schlenk, Hanno Glimm, Stefan Fröhling, Peter Horak, Leonidas Apostolidis, Marinela Augustin, Daniela Aust, Irfan Ahmed Bhatti, Johannes Bloehdorn, Cornelia Brendel, Christian Britschgi, Jan Braess, Stefan Burdach, Elena Busch, Jozefina Casuscelli, Alexander Desuki, Thomas Deutsch, Mareike Dietrich, Thomas J Ettrich, Johanna Falkenhorst, Tanja Fehm, Anne Flörcken, Andrea Forschner, Stefan Fuxius, Maria Gonzales-Carmona, Frank Griesinger, Sabine Grill, Stefan Gröschel, Georg Martin Haag, Ulrich Haag, Niels Halama, Holger Hebart, Nina Heidger, Barbara Hermes, Georg Hess, Simone Hettmer, Manuela Hoechstetter, Martin Hoffmann, Anna L Illert, Maximilian Jenzer, Bernd Kasper, Stefan Kasper-Virchow, Thomas Kindler, Ewa Koscielniak, Jan Krönke, Michael Kühn, Volker Kunzmann, Alois Lang, Jonas Leichsenring, Elisabeth Livingstone, Lucia Liotta, Kim Luley, Elisabeth Mack, Uwe M Martens, Klaus Metzeler, Jan Moritz Middeke, Lino Möhrmann, Roopa Jayarama-Naidu, Lukas Perkhofer, Arne Pfeufer, Constantin Pixberg, Michael Quante, Bernhard Rendenbach, Damian Rieke, Christian Rothermundt, Andre Norbert Sagerer, Martin Salzmann, Dieter Saur, Bastian Schilling, Jan Schleicher, Anke Schlenska-Lange, Thomas Schmidt, Sophia Schmitz, Rajiv Shah, Khalid Shoumariyeh, Alexander Siebenhüner, Martin Singh, Jens Siveke, Helen Starke, Sophia Strobel, Veronica Teleanu, Niklas Thon, Sebastian Wagner, Thomas Walle, Benedikt Westphalen, Bettina Whitlock, Eva Winkler, Naita Maren Wirsik, Lena Woydack, Angelika Zabel-du Bois, Stefanie Zschäbitz

“…ESMO Open…”
Get full text

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine by Joris van de Haar, Louisa Hoes, Emile Voest

“…ESMO Open…”
Get full text

How I treat anal squamous cell carcinoma by Erika Martinelli, Luca Poliero, Giulia Martini, Gianluca Arrichiello, Carola Borrelli

“…ESMO Open…”
Get full text

ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer by Silvia Catanese

“…ESMO Open…”
Get full text

Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration by Peter JM Openshaw, J Kenneth Baillie, Malcolm G Semple, Carlo Palmieri, Daniel Palmer, Lance Turtle

“…ESMO Open…”
Get full text

How I treat cancer: treatment of rheumatological side effects of immunotherapy by Michael G McCusker, Alessandro Russo, Katherine A Scilla, Ranee Mehra, Christian Rolfo

“…ESMO Open…”
Get full text

Aurora kinases in ovarian cancer by Valentina Gambardella, Andrés Cervantes, J Alejandro Pérez-Fidalgo, Begoña Pineda, Octavio Burgues, Oscar Piñero

“…ESMO Open…”
Get full text

Prevention of venous thromboembolism in ambulatory patients with cancer by Marc Carrier, Alok A Khorana, Alexander T Cohen, Guy Meyer, Petr Kavan, Philip S Wells

“…ESMO Open…”
Get full text

A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and after diagnosis - an Eastern European perspective by Alfredo Carrato, Lucjan Wyrwicz, Agnes Benedict, Josep M Borras, Eloy Espin-Basany, Zorana Maravic, Iga Rawicka, Anna Horvath, Vassiliki Fotaki, Ana Ruiz-Casado, Agota Petrányi, Liesbeth Lemmens, Jadranka Stanisic Trenevski

“…ESMO Open…”
Get full text

Implementing clinical practice guidelines: time to assess it by George Pentheroudakis, Jean-Yves Douillard, Nicoletta Colombo, Nicole Concin, Pauline Wimberger, Cristiana Sessa, Giuseppe Curigliano, Stefan Rauh, Carien L Creutzberg, Klizia Marinoni

“…ESMO Open…”
Get full text

Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making? by Judith Balmaña, Benedetta Pellegrino, Joaquin Mateo, Violeta Serra

“…ESMO Open…”
Get full text

Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma by Emilie Le Rhun, Nicolaus Andratschke, Michael Weller, Patrick Devos, Luca Regli, Reinhard Dummer, Laurent Mortier, Fabian Wolpert, Maud Fialek, Nicolas Reyns

“…ESMO Open…”
Get full text

Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas by Teresa Tse, Carlos King Ho Wong, Herbert Ho-fung Loong, Yihui Wei, Sampson Sui Chun Kwan, Yingjun Zhang, Yat-Ming Lau, Linda K S Leung, Gordon C H Tang

“…ESMO Open…”
Get full text

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion by Christoph Zielinski, Ahmad Awada, Joseph Gligorov, Guy Jerusalem, Christian Singer

“…ESMO Open…”
Get full text

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial by Francesca Poggio, Lucia Del Mastro, Florentine S Hilbers, Saranya Chumsri, Noam F Pondé, Dominique Agbor-Tarh, Otto Metzger-Filho, Larissa A Korde, Olena Werner, Volker Moebus, Alvaro Moreno-Aspitia, Martine J Piccart

“…ESMO Open…”
Get full text

Molecular target: pan-AKT in gastric cancer by Ian Chau, Byung Woog Kang

“…ESMO Open…”
Get full text

New emerging targets in cancer immunotherapy: the role of neoantigens by Leticia De Mattos-Arruda, Juan Blanco-Heredia, Carmen Aguilar-Gurrieri, Jorge Carrillo, Julià Blanco

“…ESMO Open…”
Get full text

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors by Sanna Iivanainen, Jarkko Ahvonen, Aija Knuuttila, Satu Tiainen, Jussi Pekka Koivunen

“…ESMO Open…”
Get full text

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians by Linda Mileshkin, Florian Lordick, Solange Peters, Nick Pavlakis, Deme Karikios, Grace Chazan, Fanny Franchini, Marliese Alexander, Prunella Blinman, Rob Zielinski, David Ball, Gavin Wright, Maarten IJzerman, Benjamin Solomon

“…ESMO Open…”
Get full text

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer by Robert Pirker, Martin Filipits

“…ESMO Open…”
Get full text